Beranda › Mieloma Multipel
Uji klinis Mieloma Multipel yang merekrut di AS
239 studi untuk Mieloma Multipel merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Columbus, OH24 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Baldwin Park, CA23 studi
- Chicago, IL22 studi
- Washington, DC22 studi
- Seattle, WA22 studi
- Edison, NJ22 studi
- Miami, FL21 studi
- Milwaukee, WI21 studi
- Charlotte, NC21 studi
- Salt Lake City, UT21 studi
- Queens, NY20 studi
- Detroit, MI19 studi
- Jacksonville, FL18 studi
- Birmingham, AL18 studi
- Los Angeles, CA17 studi
- Cincinnati, OH17 studi
- Dallas, TX17 studi
- Phoenix, AZ16 studi
- Philadelphia, PA16 studi
- Cleveland, OH16 studi
- Omaha, NE16 studi
- Tampa, FL15 studi
- Cedar Rapids, IA15 studi
- San Francisco, CA15 studi
- New Haven, CT14 studi
- Winston-Salem, NC14 studi
- Clifton, NJ14 studi
- Irvine, CA14 studi
- New Rochelle, NY14 studi
- Baltimore, MD13 studi
- Portland, OR13 studi
Berdasarkan negara bagian
- Alabama22 studi
- Arizona28 studi
- Arkansas9 studi
- California70 studi
- Colorado37 studi
- Connecticut18 studi
- Delaware4 studi
- Distrik Columbia10 studi
- Florida55 studi
- Georgia49 studi
- Idaho3 studi
- Illinois31 studi
- Indiana19 studi
- Iowa17 studi
- Kansas12 studi
- Kentucky15 studi
- Louisiana9 studi
- Maine3 studi
- Maryland25 studi
- Massachusetts44 studi
- Michigan26 studi
- Minnesota30 studi
- Missouri27 studi
- Montana4 studi
- Nebraska18 studi
- New Hampshire4 studi
- New Jersey38 studi
- New Mexico5 studi
- New York75 studi
- North Carolina52 studi
- North Dakota5 studi
- Ohio46 studi
- Oklahoma3 studi
- Oregon20 studi
- Pennsylvania23 studi
- Rhode Island6 studi
- South Carolina9 studi
- South Dakota3 studi
- Tennessee32 studi
- Texas53 studi
- Utah21 studi
- Virginia20 studi
- Washington30 studi
- West Virginia3 studi
- Wisconsin28 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Menerima pesertaFase 2
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06679829Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06904066A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07582432Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06630104A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07589634The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07850284A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05519085Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06948084A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07409246A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07391657Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT02682667Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Menerima pesertaFase 2
Usia 18 hingga 72 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT03412877A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05652335Tissue Collection for Studies of Lymph Cancer
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01676805A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04973605A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05552222A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07258511A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06500884A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07149857A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05201781A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04634552Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Menerima pesertaFase 2
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06052826A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05623020A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06768489Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.